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Abstract
In humans, spinal cord lesions induce not only major motor and neurovegetative deficits but also severe neuropathic pain
which is mostly resistant to classical analgesics. Better treatments can be expected from precise characterization of
underlying physiopathological mechanisms. This led us to thoroughly investigate (i) mechanical and thermal sensory
alterations, (ii) responses to acute treatments with drugs having patent or potential anti-allodynic properties and (iii) the
spinal/ganglion expression of transcripts encoding markers of neuronal injury, microglia and astrocyte activation in rats that
underwent complete spinal cord transection (SCT). SCT was performed at thoracic T8–T9 level under deep isoflurane
anaesthesia, and SCT rats were examined for up to two months post surgery. SCT induced a marked hyper-reflexia at
hindpaws and strong mechanical and cold allodynia in a limited (6 cm2) cutaneous territory just rostral to the lesion site. At
this level, pressure threshold value to trigger nocifensive reactions to locally applied von Frey filaments was 100-fold lower
in SCT- versus sham-operated rats. A marked up-regulation of mRNAs encoding ATF3 (neuronal injury) and glial activation
markers (OX-42, GFAP, P264, P267, TLR4) was observed in spinal cord and/or dorsal root ganglia at T6-T11 levels from day 2
up to day 60 post surgery. Transcripts encoding the proinflammatory cytokines IL-1b, IL-6 and TNF-a were also markedly but
differentially up-regulated at T6–T11 levels in SCT rats. Acute treatment with ketamine (50 mg/kg i.p.), morphine (3–10 mg/
kg s.c.) and tapentadol (10–20 mg/kg i.p.) significantly increased pressure threshold to trigger nocifensive reaction in the
von Frey filaments test, whereas amitriptyline, pregabalin, gabapentin and clonazepam were ineffective. Because all SCT rats
developed long lasting, reproducible and stable allodynia, which could be alleviated by drugs effective in humans, thoracic
cord transection might be a reliable model for testing innovative therapies aimed at reducing spinal cord lesion-induced
central neuropathic pain.
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Introduction
Spinal cord injury (SCI) is a debilitating state which causes not
only severe motor dysfunctions, loss of bladder control and
impairment of sexual function, but also chronic pain, especially
neuropathic pain [1,2]. Pain can be so severe that some SCI
patients would be ready to privilege pain relief at the expense of
further deficits in bladder control or sexual function. SCI-induced
central neuropathic pain can be localized above-, at- or below- the
level of injury and is mostly characterized by allodynia refractory
to conventional treatments [2,3].
Several animal models of SCI-induced neuropathic pain have
been developed (through spinal cord contusion, compression,
ischemia, section; see [4]), each of them displaying different
characteristics in terms of localization, duration, type of pain and
even responses to drugs. Although some studies did provide
relevant data regarding treatment efficacy and underlying
molecular mechanisms [5–7], they focused mostly on pain below
the lesion produced by contusion or clip compression of the spinal
cord. Yet, despite the fact that these SCI models reproduce
adequately some types of spinal cord injuries seen in humans, they
suffer from limitations because of unavoidable, large, interindi-
vidual variations in the extent and severity of evoked lesions [8,9].
Furthermore, lesion-induced neuroinflammatory processes could
be highly variable among SCI rats which underwent the very same
lesion procedure [10], so that characterization of actual physio-
pathological mechanisms underlying neuropathic pain might be a
real challenge in, at least, some SCI models.
In contrast to these models, complete transection of the spinal
cord would be cleared of such limitations due to unavoidable
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interindividual variations in the extent and severity of the lesion.
Indeed, spinal cord transection (SCT) has already been widely
used to study the mechanisms of subsequent locomotor recovery
[11–13] and reorganization of the somatosensory system [14–15]
in medullary lesioned rats. However, to date, only few studies
showed that the SCT model could be used to investigate spinal
lesion-induced neuropathic pain [16], and, indeed, some authors
even reported that no neuropathic pain develops in rats with
complete SCT [17,18].
These discrepant data led us to reinvestigate whether or not the
rat model consisting of complete SCT at the thoracic level could
be a relevant model of central neuropathic pain, allowing studies
of underlying physiopathological mechanisms and responses to
drugs with patent or potential alleviating properties. Nocifensive
responses to mechanical and thermal stimulations were assessed
using the validated von Frey filaments test and the paw immersion
and acetone drop tests, respectively. We then investigated whether
responses to these tests could be affected by acute treatments with
various drugs (opioids, antidepressants, anticonvulsants and others)
known to alleviate neuropathic pain in SCI patients. Finally, we
analyzed by real time quantitative RT-PCR, at different times
after thoracic cord transection, the expression of mRNAs encoding
proteins implicated in neuroinflammation and neuroplasticity,
with particular focus on markers of microglia and astrocyte
activation, pro- and anti-inflammatory cytokines (Interleukins IL-
1b, IL-6 and IL-10, Tumor Necrosis Factor alpha,TNF-a), Brain-
Derived Neurotrophic Factor (BDNF) and nociceptive signaling
pathways in dorsal root ganglia (DRG) and spinal cord tissues, for
comparison with previous studies aimed at unveiling physiopath-
ological mechanisms associated with neuropathic pain in other
SCI models.
Materials and Methods
Animals and Ethics Statements
Male Sprague–Dawley rats, weighing 225–250 g (7–8 weeks
old) on arrival in the laboratory, were purchased from Janvier
Breeding Center (53940 Le Genest Saint Isle, France). They were
housed under standard controlled environmental conditions
(2261uC, 60% relative humidity, 12:12 h light–dark cycle, lights
on at 7:00 am), on ground corn cobs (GM-12, SAFE, 89290,
Augy, France), with complete diet for rats/mice/hamster (105,
SAFE, 89290, Augy) and tap water available ad libitum. Before
surgery, rats were housed 5 per cage (40640 cm, 20 cm high) and
allowed to habituate to the housing facilities without any handling
for at least 1 week before being used. After surgery, all efforts were
made to minimize suffering. In particular, SCT rats were housed
under the very same conditions, except that each cage was for only
two operated rats, so as to avoid as much as possible allodynic
contacts between them. All animals were thoroughly examined
each day, and in case of any sign of abnormal physiological
alterations or suffering appeared, they were immediately sacrificed
by a lethal dose of pentobarbital (150 mg/kg i.p.), strictly following
the recommendations of the Ethical Committee of the French
Ministry of Research and High Education (articles R.214–124,
R.214–125). Both the Ethics and Scientific Committee of the
French Institut pour la Recherche sur la Moelle Epinie`re et l’Ence´phale
(IRME; contract to M.H., 2010–2011) and the national (French)
Committee for Animal Care and Use for Scientific Research
(registration nb.01296.01; official authorization B75-116 to M.H.,
31 December 2012) specifically approved the study.
In addition, the Ethical Guidelines of the Committee for
Research and Ethical Issues of the International Association for
the Study of Pain [19] and the Institutional Guidelines in
compliance with French and international laws and policies
(Council directive 87–848, October 19, 1987, Ministe`re de
l’Agriculture et de la Foreˆt, Service ve´te´rinaire de la sante´ et de la protection
animale, permissions nb A752128 to S.M., 006228 to S.B., nb
00482 to V.K.) were strictly followed.
Spinal Cord Transection
Animals underwent surgery under deep isoflurane anaesthesia
(3%). Paravertebral muscles were cut bilaterally and the T8
vertebra was opened using a gouge-forceps. Local anaesthesia was
made by cooling the spinal cord with cryoflurane (Promedica,
France) a few seconds before the lesion. Complete transverse
section with ophthalmic scissors at the T8–T9 spinal cord
segments level was performed following the procedure described
by Antri et al. [11], then sterile absorbable haemostatic gel foam
(Surgicel; Ethicon, Somerville, NJ, USA) was inserted into the
lesion. Sham-operated animals underwent laminectomy only. At
the last step of surgery, muscles were sutured and the skin was
closed up by skin clips. Both SCT and sham-operated rats then
received antibiotic treatments to prevent staphylococcic infection
(oxacillin, Bristol Myers Squibb S.P.A., Italy, 0.3 mg/100 g s.c.
once a day during 7 days) and urinary infection (gentamicin,
Panpharma, France, 0.2 mg/100 g s.c., immediately after the
surgery). No further treatment was administered to operated
animals, to avoid potential interference with the development of
allodynia and hyperalgesia. For recovery, SCT and sham rats were
housed two per cage. The bladder of SCT rats was emptied
manually once daily until reappearance of the voiding reflex
(usually before the 10th day post surgery) (see Results).
Tests with Von Frey Filaments
Assessment of At-Level Mechanical Allodynia. For assess-
ment of SCT-induced neuropathic-like pain in the cutaneous
territory bordering surgery scar, rats were placed individually into
a plastic cage (42624615 cm) and allowed to adapt to this
environment for 1 hour before any stimulation. Tactile allodynia
was then looked for with a graded series of von Frey filaments
(Bioseb, 92370 Chaville, France) producing a bending force
ranging between 0.008 g and 100 g. The threshold pressure to
trigger a response (see below) was determined using the ‘‘up-
down’’ method [20]. The stimuli were applied 3 times (3 seconds
apart) for each filament, within a cutaneous territory of about
6 cm2 just rostral to the lesion (see Results). When positive
nociceptive behaviors, consisting of either a shake, an attack
(filament biting), or an escape reaction [5,20], occurred, the next
lower pressure-von Frey filaments were tested down to the
filament producing no response. Then, the next higher pressure-
filaments were applied back to the one triggering a response. The
minimal force filament causing at least one of these responses
(usually biting) allowed determination of the mechanical pressure
threshold value. The 100 g filament, chosen as cut-off to prevent
tissue injury, induced no nociceptive behavior in the majority (.
90%) of naı¨ve rats. To avoid nonspecific responses, only these
‘‘non-reactive’’ rats were selected for surgery and included in the
study.
Assessment of Mechanical Sensitivity in Body Territories
Outside the Allodynic Area. SCT and sham-operated rats
were also subjected to mechanical stimulation with von Frey
filaments to assess evoked responses at the level of forepaws,
hindpaws, vibrissae pad and other body territories outside the
allodynic 6 cm2 area just rostral to the surgery scar. For these tests,
each rat was placed on a wire grid platform (565 mm mesh) under
a small plastic (35620615 cm) cage for 2 hours, and mechanical
sensitivity was determined with a graded series of 9 von Frey
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filaments (bending force of 4, 6, 8, 10, 12, 15, 26, 60 and 100 g).
The ‘‘up-down’’ method [20] was also used at all of these sites. At
paw level, stimuli were applied onto the lateral plantar surface of
the right forepaw or hindpaw 3 times (3 seconds apart) for each
filament. The minimal force filament for which animals presented
either a brisk paw withdrawal and/or an escape attempt allowed
determination of the mechanical pressure threshold [21]. Usually,
the mechanical pressure threshold value to trigger a (non
nocifensive) response in naı¨ve healthy rats was around 60 g.
Because SCT rats presented large time-dependent changes in
mechanical sensitivity (see Fig. 1), higher pressures were also
tested, with cut-off fixed at 100 g to avoid any tissue injury.
Assessment of Thermal Sensitivity
Paw Immersion Test. Because variations in skin tempera-
ture can affect the responses in nociceptive tests [22], we
systematically performed control experiments that consisted of
measuring hindpaw skin temperature just before the paw
immersion test. The rat was left in its cage and a thermistor
probe (Thermocouple thermometer Digi-Sense, Model Nu8528-
10; Cole-Parmer Instrument Company, Chicago, IL; 15 mm in
diameter) was applied onto the plantar surface of hindpaw. Stable
temperature readings were obtained after 10 sec with a precision
measure of 0.1uC [23].
Thermal sensitivity at the hindpaw level was determined using
the paw immersion test in both SCT and sham-operated rats [24].
Briefly, the right hindpaw was immersed into a water bath
maintained at 46uC (Polystat, Bioblock Scientific, Illkirch-Graffen-
staden, France) for heat stimulation or at 10uC (Ministat, Bioblock
Scientific) for cold stimulation, and the latency to struggle reaction
(paw withdrawal) was measured to the nearest 0.1 sec.
At-Level Cold Allodynia. Cold allodynia in SCT rats was
assessed at day 15 post-surgery using a procedure slightly adapted
from the acetone drop test described by Baastrup et al. [5]. Four
drops of 10 mL acetone were gently deposited within two seconds
all around the surgery scar in SCT and sham-operated rats. The
number of trunk shakes and the time spent in escape or licking
behavior were determined for one min after acetone drops
application.
Pharmacological Treatments
Gabapentin and pregabalin were purchased from Sequoia
(Pangbourne, UK). Amitriptyline, baclofen, ketamine and 8-OH-
DPAT [(6)-8 hydroxy-2-dipropylamino-tetralin] were from Sig-
ma-Aldrich (Saint-Quentin Fallavier, France). Other compounds
Figure 1. Time-course changes in the pressure threshold value to trigger hindpaw withdrawal in spinal cord-transected rats.
Pressure threshold values were determined using a graded series of von Frey filaments applied onto hindpaw. Each point is the mean + S.E.M. of
independent determinations in 6 rats. « Cut-off SCT » corresponded to the maximal pressure tested in spinal cord-transected rats; even at this high
pressure level (100 g), no response of hindpaws was evoked for the first 9 days post-surgery. The « Threshold sham » corresponded to the minimal
pressure (60 g) to which sham-operated animals start to respond by hindpaw withdrawal. ** P,0.01, *** P,0.001, significantly different from 100 g
« cut-off SCT » value. One-way ANOVA for repeated measures followed by Dunnett’s test.
doi:10.1371/journal.pone.0102027.g001
Spinal Cord Transection-Induced Allodynia in Rats
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e102027
were clonazepam (Roche, Basel, Switzerland), cyclotraxin B (BIO
S&T, Montreal, Canada), morphine (Pharmacie Centrale des
Hoˆpitaux de Paris, France), tapentadol (Gru¨nenthal, Aachen,
Germany), naratriptan and ondansetron (Glaxo Wellcome,
Harlow, UK).
All treatments were administered between 2 pm and 4 pm.
Routes of administration and doses (as free bases; see Table 1)
were chosen according to previous data in the literature (see
appropriate references in sections of Results and Discussion). All
drugs were dissolved in saline (0.9% NaCl) except baclofen which
was dissolved in dimethyl-sulfoxide (DMSO):0.9% NaCl (50:50)
and clonazepam in ethanol:water (50:50). Drugs or their vehicles
were injected acutely 30 days after thoracic cord transection, when
mechanical allodynia had fully developed in the 6 cm2 area just
rostral to the lesion (see Results). For intrathecal injections (of
ondansetron), rats were briefly anaesthetized with isoflurane (3%
in air), and the needle (26 G) was inserted into the lumbar space
between the L5 and L6 vertebrae [25] for administration of the
appropriate dose in 20 mL of saline. Von Frey filaments test was
then applied (by a skilled experimenter blind to treatments) at
various times after acute drugs administration to determine the
time course of drug-induced changes in pressure threshold value to
trigger nocifensive response (biting of the filament, see Results),
until the drug effect completely disappeared. In all experiments,
only one treatment was administered per rat.
Real Time Quantitative RT-PCR Measurements
SCT- and sham-operated rats were decapitated at various
times, from 2 to 60 days, after surgery. DRG, thoracic cord
segments below (T9–T11) and above (T6–T8) the lesion, along
with cervical and lumbar enlargements, were rapidly dissected out
at 0–4uC, and immediately frozen in liquid nitrogen to be stored at
280uC. In some experiments, spinal cord samples were further
sectioned by a medio-vertical cut to separate dorsal and ventral
halves. Total RNA was extracted using the NucleoSpin RNA II
extraction kit (Macherey-Nagel, 67722 Hoerdt, France) and
quantified using NanoDrop. First-stranded cDNA synthesis (from
660 ng total RNA per 20 mL reaction mixture) was carried out
using High Capacity cDNA reverse transcription kit (Applied
Biosystems, Courtaboeuf, France). PCR amplification, in triplicate
for each sample, was performed using ABI Prism 7300 (Applied
Biosystems), TaqMan Universal PCR Master Mix No AmpErase
UNG (Applied Biosystems) and Assays-on-Demand Gene Expres-
sion probes (Applied Biosystems) for targets’genes: ATF3 (assay ID
Rn00563784_m1), GFAP (Rn01460868_m1), OX-42
(Rn00709342_m1), IL-1b (Rn00580432_m1), IL-6
(Rn00561420_m1), TNF-a (Rn00562055_m1), IL-10
(Rn00563409_m1), BDNF (Rn02531967_s1), TLR4
(Rn00569848_m1), P264 (Rn00580949_m1), P267
(Rn00570451_m1). mRNA determinations were made with
reference to the reporter gene encoding glyceraldehyde 3-
phosphate dehydrogenase (GaPDH; Rn99999916_s1). The poly-
merase activation step at 95uC for 15 min was followed by 40
cycles of 15 s at 95uC and 60 s at 60uC. The validity of the results
was checked by running appropriate negative controls (replace-
ment of cDNA by water for PCR amplification; omission of
reverse transcriptase for cDNA synthesis). Specific mRNA levels
were calculated after normalizing from GaPDH mRNA in each
sample. Data are presented as relative mRNA units compared to
control (sham) values (see [21]).
Statistical Analyses
All values are expressed as means 6 S.E.M. For von Frey
filaments tests, the data were analyzed by one-way ANOVA for
repeated measures (effect of a drug over time) followed by
Dunnett’s test. Statistical evaluations of SCT-induced changes in
behavioral responses to thermal stimulations were made using the
Student’s t test. For qRT-PCR data, the 22DDCt method [26] was
used for analysis of the relative changes in specific mRNA levels
and for graphic representations (RQ Study Software 1.2 version;
Applied Biosystems). For analysis of the time course expression of
the targets’genes, a two-way ANOVA was performed, followed by
Bonferroni test for comparison of SCT rats versus respective
Table 1. Pharmacological treatments tested for potential anti-allodynic effects in spinal cord-transected rats.
Drugs Pharmacological effect Dose
Efficacy on biting
behavior
Morphine Opioid receptor agonist 1, 3, 10 mg/kg s.c. +++
Tapentadol Opioid receptor agonist and noradrenaline reuptake inhibitor 10, 20 mg/kg i.p. +++
Ketamine NMDA receptor antagonist 50 mg/kg i.p. ++
Baclofen GABA B receptor agonist 10 mg/kg i.p. +
Clonazepam Benzodiazepine (agonist) 0.25, 2 mg/kg i.p. -
Gabapentin Blockade of calcium channel a2d subunit 30, 100, 300 mg/kg i.p. -
Pregabalin Blockade of calcium channel a2d subunit 30 mg/kg i.p. -
Amitriptyline Tricyclic antidepressant 10 mg/kg i.p. -
Amitriptyline + Gabapentin Tricyclic antidepressant + Blockade of
calcium channel a2d subunit
10 mg/kg i.p. +100 mg/kg i.p. -
Cyclotraxin B TrkB receptor blocker 20 mg/kg i.p. -
Naratriptan 5-HT1B/D receptor agonist 0.1 mg/kg i.p. -
Ondansetron 5-HT3 receptor antagonist 20 mg i.t. -
8-OH-DPAT 5-HT1A/7 receptor agonist 0.25 mg/kg i.p. -
+++: potent anti-allodynic effect (complete recovery of control mechanical sensitivity);
++: potent but short lasting anti-allodynic effect;
+: modest but significant anti-allodynic effect; -: inactive treatment.
doi:10.1371/journal.pone.0102027.t001
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(sham) controls at each time. The critical level of statistical
significance was set at P,0.05.
Results
Physiological State of Spinal Cord Transected Rats
After full recovery from anaesthesia, SCT rats first showed
hindlimb paralysis and flabbiness. Although they moved in their
cage without major difficulty and could access food and water as
readily as before the surgery, SCT rats stopped gaining weight for
the first week after surgery (26.363.8 g, mean 6 S.E.M., n = 8),
in contrast to sham-operated animals (+4362 g, mean 6 S.E.M.,
n = 8); but, afterwards, weight gain was parallel in both SCT- and
sham-operated rats (+175.4628.3 g and +171.2612.5 g from day
7 to day 30 post-surgery, respectively, means 6 S.E.M., n = 8 in
each group).
Most striking symptoms were urinary retention and/or hema-
turia. Hematuria disappeared after 3 or 4 days without any specific
treatment. To deal with urinary retention, we had to trigger off the
miction reflex by rubbing the bladder once a day during 8–9 days
on average. Then, the reflex recovered completely. It also
happened that some SCT rats had an accelerated gut transit with
diarrhea for the first 3 days post surgery. Later on, such gut
disorders were only exceptionally observed. On the other hand,
SCT rats had their fur a little bit more tousled than sham animals,
but it stayed very clean in areas located both rostrally and caudally
of the lesion site, most probably through grooming (that we
regularly noted) by their cage mate. Abnormal suffering (with signs
such as skin scratching) and/or autotomy were never observed
when SCT rats were housed two per cage, as always used for these
studies.
Immediately after the surgery and during usually 9–10 days,
SCT rats showed paraplegia, first characterized by a total absence
of reaction when hindlimbs were mechanically stimulated with von
Frey filaments exerting pressure up to the cut-off value (100 g)
(Fig. 1). This was followed by a hypo-reflexia which progressively
vanished up to normal-like response (as in control unoperated rats)
to mechanical stimulation which was usually recovered two weeks
post surgery. Later on, SCT rats developed a hyper-reflexia with a
pressure threshold value to trigger brisk hindpaw withdrawal
strikingly lower (280%) than that determined in sham rats up to at
least 7 weeks post-surgery (Fig. 1). All along the observation
period, SCT rats had paralyzed hindlimbs with spasticity, rigidity
and tonicity. They also had frequent spontaneous movements of
the tail and hindlimbs (shaking), and developed uncoordinated
flexion and extension movements.
Development and Localization of Mechanical Allodynia
Among all the body areas tested, only the lesion site on the back
and the hindlimbs (see above) showed altered behavioral responses
in the von Frey filaments test in SCT- compared to sham-operated
rats.
Within a few days after SCT, supersensitivity to mechanical
stimulation appeared at the lesion site. From day 2 to day 9, such
supersensitivity was mostly rostro-lateral to the lesion site within
small areas on both sides (Fig. 2). Then, the supersensitive territory
extended medially and laterally to cover an approximately 6 cm2
cutaneous area just rostral to the thoracic cord transection. In
contrast, no supersensitivity was detected behind the transection,
and, indeed, SCT rats did not react even to a 100 g pressure
exerted by von Frey filament applied within the cutaneous
territory on the back, caudal to the transection.
Further assessment of supersensitivity to application of von Frey
filaments within the 6 cm2 area just rostral to the lesion led to
identify three different aversive reactions: biting, shaking and
escape (Fig. 3), in agreement with previous observations in SCI
rats [5]. Determinations of pressure threshold values to trigger
each of these behaviors showed parallel time-course decreases,
down to very low levels that were reached 10–14 days after surgery
and remained unchanged for the 7-weeks-observation period
(Fig. 3).
Thermal Sensitivity
To make sure that no bias due to possible changes in skin
temperature occurred in SCT- versus sham-operated rats, we first
measured hindpaw skin temperature just prior performance of the
paw immersion test, two weeks post surgery. Under controlled
environmental conditions (with ambient temperature at 2261uC;
see Materials and Methods), hindpaw skin temperature was of
30.161.0uC and 29.860.5uC (means 6 S.E.M. of 8 independent
determinations in each group) in SCT- and sham-operated rats,
respectively, indicating the lack of incidence of SCT on this
parameter. However, clear-cut differences between SCT- and
sham-operated rats were noted in withdrawal latencies after
hindpaw immersion in cold (10uC) as well as hot (46uC) water. As
shown in Figure 4A, SCT rats reacted with much shorter latencies
compared to sham-operated animals, as expected of increased
sensitivity to both cold and hot stimulation two weeks post SCT.
Further evaluation of cold hypersensitivity was made using the
acetone drop test applied at the lesion site, where SCT rats
developed mechanical allodynia (Fig. 2). As illustrated in Figure 4B,
both the number of trunk shakes and the time spent in back licking
and escape attempts for the first min after acetone drops
application were significantly increased in SCT- compared to
sham-operated animals (+67% and +400%, respectively).
Pharmacological Studies
Effects of Opioı¨dergic Drugs (Morphine and Tapentadol)
on At-Level Mechanical Allodynia. As treatments with opioids
were shown to reduce pain in humans with spinal cord lesions
[27,28], we investigated whether morphine (1, 3 and 10 mg/kg
s.c.) was effective to reduce at-level mechanical allodynia in SCT-
rats. Acute treatment was performed 30 days after the surgery,
when pressure threshold to elicit biting behavior in response to von
Frey filament application had reached its minimum value (Fig. 3).
As illustrated in Figure 5A, morphine exerted a dose-dependent
effect: it was inactive at 1 mg/kg s.c., but increased pressure
threshold value at higher doses, with complete suppression of
allodynia-like response 30 and 60 min after administration of the
highest dose tested (10 mg/kg s.c.). Confirmation of the anti-
allodynic efficacy of opiate receptor activation was made with
tapentadol, a mixed mu opioid receptor agonist and noradrenaline
reuptake inhibitor with potent antalgic properties [29], which also
reversed SCT-induced mechanical allodynia in a dose-dependent
manner. As shown in Figure 5B, tapentadol at 10 mg/kg i.p.
slightly increased the pressure threshold value, but the dose of
20 mg/kg i.p. completely suppressed allodynia-like response 30
and 60 min after its administration to SCT rats.
Effects of Ketamine on At-Level Mechanical
Allodynia. Ketamine is well known to reduce pain in humans
suffering from spinal cord injury, and its pain alleviating efficacy
has also been reported in rat models of SCI, such as the one
obtained by spinal cord contusion [30]. In SCT rats, acute
administration of ketamine (50 mg/kg i.p.) induced a significant
increase in pressure threshold value to trigger nocifensive response
to von Frey filament application within the allodynic cutaneous
area (Fig. 5C). At its maximum, 30 min after treatment, pressure
threshold value reached 77.3617.6 g (from 0.96 g60.39 g before
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treatment, means 6 S.E.M. of 6 determinations), which was not
significantly different from the cut-off value corresponding to the
non-allodynic state (in naı¨ve rats, before surgery). However, this
effect vanished rapidly because mechanical allodynia was com-
pletely restored 90 min after ketamine administration (Fig. 5C).
Effects of Baclofen on At-Level Mechanical
Allodynia. Because baclofen, a GABA B receptor agonist, is
often prescribed to reduce SCI-induced spasticity in humans, and
is endowed with anti-neuropathic pain properties [31], we
investigated whether this drug could reduce at-level mechanical
allodynia in SCT rats. Indeed, baclofen induced a limited and
transient increase (p,0.05) in pressure threshold value, from
0.660.4 g before treatment to 5.062.1 g 30 min after i.p.
administration of this drug at 10 mg/kg (Fig. 5D).
Effects of Anticonvulsant Drugs on At-Level Mechanical
Allodynia. The calcium channel blockers gabapentin and
pregabalin and the benzodiazepine clonazepam are anticonvul-
sants endowed with anti-neuropathic pain properties both in
humans [3,27] and in rodent models [32,33], and we tested
whether these drugs also exerted anti-allodynic effects in SCT rats.
In fact, acute treatments with either gabapentin (30 mg/kg i.p.),
pregabalin (30 mg/kg i.p.) or clonazepam (0.25 mg/kg i.p.), at
doses devoid of any inhibitory effect on locomotor coordination (as
assessed using the rotarod test; not shown), had no significant effect
on pressure threshold to trigger nocifensive response in SCT rats
(Table 1). Some increase in pressure threshold values was noted
with higher doses of clonazepam (2 mg/kg i.p.) and gabapentin
Figure 2. Body territories with increased mechanical sensitivity in spinal cord-transected rats. Pressure threshold values to trigger
nocifensive responses were determined using a graded series of von Frey filaments applied throughout the body. Comparison with sham-operated
rats (C) showed that pressure threshold values differed in SCT rats only in a limited territory (6 cm2) bordering rostrally the spinal cord section (at T8–
T9, horizontal bar with arrow heads) and in hindpaws (black areas tested), where reactions were obtained for pressure values significantly less than in
controls. Time course (day 2 to day 60) changes in spinal cord transected rats showed that supersensitivity (allodynia) in the at-level area just rostral
to the lesion was already detected at day 2 (D2) post-surgery, then extended and increased up to a plateau reached at D14 post-surgery. At hindpaw
level, supersensitivity developed much later (from D21 post-surgery). Data were obtained in 8–14 rats at each time.
doi:10.1371/journal.pone.0102027.g002
Figure 3. Time-course changes in nocifensive reactions to von Frey filaments application in the « at-level » allodynic territory
rostral to the lesion in spinal cord-transected rats. Pressure threshold values to trigger biting (of the filament), shaking or escape were
determined using the ‘‘up-down’’ method with a graded series of von Frey filaments applied onto the allodynic at-level area on the back at various
times (in days) after surgery (0 on abscissa). Each bar is the mean + S.E.M. of independent determinations in 8 rats. *** P,0.001 compared to control
(intact) rats (C on abscissa). One-way ANOVA for repeated measures followed by Dunnett’s test.
doi:10.1371/journal.pone.0102027.g003
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(100 and 300 mg/kg i.p.), but rats presented profound ataxia after
such treatments (not shown).
Effects of Other Drugs on At-Level Mechanical
Allodynia. As detailed in Table 1, the antidepressant amitrip-
tyline, alone or combined with gabapentin, the anti-migraine drug
naratriptan, the 5-HT1A/7 receptor agonist 8-OH-DPAT, the 5-
HT3 receptor antagonist ondansetron, the BDNF-Trk B receptor
blocker cyclotraxin B, at effective doses to reduce pain in validated
neuropathic models in rodents [34–39], exerted no anti-allodynic
effects up to 3 hours after acute administration in SCT rats.
Neuroinflammatory and Neuroplasticity Markers in Spinal
Cord and DRG of SCT rats
Spinal Cord. A first series of determinations consisted of
measuring the tissue concentrations of transcripts encoding the
neuronal injury marker ATF3, the macrophage-microglial activa-
tion marker OX-42 and the astrocytic marker GFAP [21] in the
dorsal and ventral halves of spinal cord segments just above (T6–
T8) and just below (T9–T11) the surgery level in SCT- compared
to sham-operated rats. Measurements were made at day 17 post
surgery, when both mechanical (Fig.3) and thermal (Fig.4)
allodynia had fully developed. As shown in Figure 6, expression
of these three genes was markedly upregulated in both dorsal and
ventral halves in segments above and below the section compared
to sham-operated rats. Upregulation of ATF3 mRNA was slightly
larger in dorsal spinal cord above and below SCT (620.8- and
621.1-fold, respectively) than in the corresponding ventral spinal
cord segments (615.7 and615.1-fold, respectively). On the other
hand, no significant differences were noted between SCT-induced
elevation of OX-42 mRNA and GFAP mRNA levels in the dorsal
versus the ventral halves of spinal segments above and below SCT.
Accordingly, no further distinction between the dorsal and ventral
halves was made in subsequent experiments, and whole spinal
cord segments were dissected out and processed for investigating
the time-course changes in neuroinflammatory and neuroplasticity
markers after thoracic cord transection.
As shown in Figure 7, already on day 2 post-surgery, ATF3
mRNA levels were 16.0- and 21.0-fold higher in thoracic spinal
cord segments just caudal and rostral to the section, respectively,
than in corresponding tissues from sham-operated rats. This up-
regulation was long lasting as it persisted, but to a lower extent, up
to the last observation day (67.0 and 6.7 on day 60 post-surgery)
(Fig. 7A). As illustrated in Figure 7A, a long lasting up regulation
of ATF3 mRNA was also detected in both the cervical and lumbar
enlargements of the spinal cord in SCT rats. However, this change
was of much lower amplitude than in thoracic segments. OX42
mRNA levels were also markedly increased in thoracic segments of
the spinal cord just caudal and rostral to the section on day 2 post-
surgery (66.2 and 4.8, respectively), and remained significantly
elevated until day 60 (62.8 and 2.5, respectively) (Fig. 7B). A long
lasting up-regulation of OX-42 mRNA was also noted in both the
cervical and lumbar enlargements of the spinal cord. However, it
was of lower amplitude than in thoracic segments (Fig. 7B). The
time course of SCT-induced changes in GFAP mRNA levels
differed from those of the former two transcripts, as the observed
up-regulation was delayed and relatively less pronounced (63 at
maximum) (Fig. 7C). However, these changes persisted to similar
extents up to the last observation day (day 60 post surgery). In
cervical and lumbar enlargements, only slight, generally non
significant, increases in GFAP mRNA levels were observed in
SCT rats, but they were also of long duration (Fig. 7C).
Concerning pro-inflammatory cytokines, a massive increase in
IL-6 mRNA levels was observed as soon as 2 days after the section
in thoracic segments bordering caudally (x 76.8 as compared to
Figure 4. Hyper-responsiveness to thermal stimulation in
spinal cord-transected rats. A – Latency (in sec) to hindpaw
withdrawal was determined after paw immersion into a bath of hot
(46uC) or cold (10uC) water, two weeks after the surgery. Each bar is the
mean + S.E.M. of independent determinations in 9 SCT rats and 5 sham-
operated rats. ** P,0.01, *** P,0.001 compared to respective values in
sham-operated rats. Student’s t test. B – Behavioral responses to the
acetone drop test applied at the surgical scar two weeks after surgery.
The number of shakes and the time (in sec) spent in escape attempts
and licking of the back were measured for one minute after acetone
drops application. Each bar is the mean + S.E.M. of independent
determinations in 8 SCT rats and 7 sham-operated rats. * P,0.05, ** P,
0.01 compared to respective values in sham-operated rats. Student’s t
test.
doi:10.1371/journal.pone.0102027.g004
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sham-operated rats) and rostrally (x 66.4) the section (Fig. 8A). A
modest up-regulation was still observed on day 15 but not on day
60 post surgery. In contrast, no significant changes in IL-6 mRNA
levels were detected in both the cervical and lumbar enlargements
of the spinal cord at any time after SCT as compared to transcript
levels measured in the same tissues of sham-operated rats (not
shown).
The levels of IL-1b mRNA were also markedly increased 2 days
after surgery in thoracic segments bordering caudally (x 172.2 as
compared to sham-operated rats) and rostrally (x 98.6) the
transection (Fig. 8B). Significant increases in IL-1b mRNA levels
still persisted in caudal- and rostral-level segments on day 60 post-
surgery, but to a much lower extent than on day 2. Similar but less
pronounced changes in TNF-a mRNA levels were noted with a
significant up-regulation in thoracic segments on day 2 post
surgery (63.0 caudally and 61.9 rostrally to the section,
respectively) (Fig. 8C). On day 60, a significant increase in TNF-
a mRNA levels was still detected principally in thoracic segments
rostral to the transection (x 1.9) (Fig. 8C). Finally, tissue
concentrations of mRNA encoding the anti-inflammatory cytokine
IL-10 were also markedly increased on day 2 after transection in
both caudal-level (x 36.3) and rostral-level (x 38.7) thoracic
segments, and an up-regulation of much lower amplitude was still
detected on day 60 post surgery (Fig. 8D).
In contrast with the aforementioned transcripts, BDNF mRNA
levels were reduced in spinal cord tissues of SCT rats, both on days
2 (249% as compared to sham-operated rats, P,0.05) and 60 (2
38%, P,0.05) post surgery in thoracic segments caudal to the
section and on day 60 (223%, P#0.05) post surgery in thoracic
segments rostral to the section (not shown). On the other hand,
mRNAs encoding P264, P267 and TLR4 were upregulated in
thoracic segments bordering caudally (63.2, 61.8 and 63.8,
respectively) and rostrally (62.6,61.5 and63.6, respectively) the
transection on day 2 post-surgery. This up-regulation was even
more pronounced on post-surgery day 60 (63.6,62.9 and64.5
caudal to the section,63.8,62.9 and65.6 rostral to the section,
respectively) (Fig. 9A, 9B, 9C).
Dorsal Root Ganglia. Like that observed at spinal level,
ATF3 mRNA was strongly up-regulated in DRG at T9–T11
caudal level as well as T6–T8 rostral level for the first two weeks
after thoracic cord transection (Fig. 7A). Then, significant
increases persisted up to the last observation day, two months
after surgery, but to a lower extent, only in T6–T8 DRG (Fig. 7A).
Transcripts encoding OX-42 (macrophages) and GFAP (satellite
Figure 5. Anti-allodynic effects of acute administration of morphine (A), tapentadol (B), ketamine (C) or baclofen (D) in spinal cord-
transected rats. Acute administration of morphine (1, 3 or 10 mg/kg s.c.), tapentadol (10 or 20 mg/kg i.p.), ketamine (50 mg/kg i.p.), baclofen
(10 mg/kg i.p.) or their respective vehicle was performed (0 on abscissa, arrow) in rats whose spinal cord had been transected at T8–T9 level one
month before. Pressure threshold values to trigger nocifensive biting were determined using von Frey filaments applied within the at-level allodynic
territory at various times after treatment. Each point is the mean + S.E.M. of independent determinations in n rats. C on abscissa: Control (naive) rats
(prior to surgery). P,0.05, ** P,0.01, *** P,0.001 compared to respective values in vehicle-treated rats. One-way ANOVA for repeated measures
followed by Dunnett’s test.
doi:10.1371/journal.pone.0102027.g005
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glial cells) were also markedly up regulated in DRG at spinal cord
segments caudal (T9–T11) and rostral (T6–T8) to the transection.
However, this effect was transient, especially at rostral level (T6–
T8) where significant increases in OX-42 and GFAP transcripts
were noted on days 2–4 and up to day 9 post-surgery, respectively.
At caudal level (T9–T11), up regulation of these transcripts lasted
a few days more, but three weeks post-surgery, both OX-42 and
GFAP transcripts no longer differed in thoracic DRG of SCT-
versus sham-rats (Figs 7B,7C).
As illustrated in Figure 8A, mRNA encoding IL-6 also showed a
dramatic up-regulation (x 65.6) in T9-T11 DRG at day 2 post
surgery. Its levels then decreased rapidly, but remained signifi-
cantly higher than in sham-operated rats up to day 9 post surgery
(x 4.4; not shown). Interestingly, up-regulation of IL-6 mRNA was
even larger at day 2 (x 145.0) and remained significant for a longer
period (up to day 50 post surgery: 61.6) in rostral level T6–T8
DRG (Fig. 8A, and data not shown). An up regulation of IL-1b
mRNA was also noted in thoracic DRG at day 2 post-surgery (but
not at day 60) in SCT rats (Fig. 8B), but this change was of much
lower amplitude than that noted at spinal level. Also in sharp
contrast with that previously noted at spinal level, TNF-a mRNA
was not up-regulated in thoracic DRG of SCT rats, neither at day
2 nor at day 60 post-surgery (Fig. 8C). Finally, the levels of mRNA
encoding the anti-inflammatory cytokine IL-10 were found to be
slightly increased (x 3.1), but only in DRG caudal to the section
(T9–T11) on day 2 post surgery, and at a markedly lower extent
than in thoracic cord segments (Fig. 8D).
Further transcripts quantifications confirmed the existence of
marked differences between DRG and spinal cord tissues. In
particular, BDNF mRNA levels were significantly increased in
caudal level T9–T11 DRG at both days 2 (65.6, P,0.01) and 55
(61.6, P#0.05) post-surgery, but only at day 2 (64.3, P,0.01) in
rostral level T6–T8 DRG (not shown). On the other hand,
mRNAs encoding P264, P267 and TLR4, which are all
expressed by activated macrophages and satellite glial cells [40–
42], showed no modification of their expression levels in T9–T11
DRG of SCT rats whatever the time after surgery. Similar
negative results were noted in T6–T8 DRG except a modest but
significant increase in P267 mRNA levels observed on day 2 post
surgery (Fig. 9A, 9B, 9C).
Discussion
Spinal cord transection is a model widely used for the study of
induced spasticity, hyper-reflexia and subsequent functional and
structural plasticity underlying locomotor recovery under the
control of the Central Pattern Generator [11–13]. Although
neuropathic pain concerns a high proportion of SCI patients, only
few investigations have been dedicated to alterations in pain
signaling mechanisms in rats with complete SCT. Indeed, a large
body of data has already been generated from studies in rodents
with partial spinal cord lesion, but unavoidable interindividual
variations in the severity and extent of lesion constitute serious
limitations of such models (see Introduction). These considerations
led us to thoroughly characterize the homogeneous model of
complete transection of the spinal cord at thoracic level with
regard to its possible relevance for studying central neuropathic
pain, associated neuroplasticity changes and responses to drugs
used to alleviate pain in SCI patients.
Figure 6. Increased expression of ATF3, OX-42 and GFAP mRNAs in the dorsal and ventral halves of spinal cord segments just
above (T6–T8) and below (T9–T11) the surgery level in spinal cord-transected rats. Real time RT-qPCR determinations were made at day
17 after surgery. Data are expressed as the ratio of specific mRNA over GaPDH mRNA [R.Q.(A.U.)]. Each bar is the mean + S.E.M. of 10 independent
determinations in both SCT (black bars) and sham-operated (empty bars) rats. *** P,0.001 compared to respective values in sham-operated rats.
Two-way ANOVA followed by Bonferroni test.
doi:10.1371/journal.pone.0102027.g006
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Clinical State of Spinal Cord Transected Rats
Despite complete transection of the spinal cord, rats showed a
relatively good physiological state. The lack of micturition reflex
and the hematuria, which are commonly encountered in
paraplegic patients [43], usually resolved within 9 days post-
surgery. Otherwise, their fur was clean, and very probably because
they shared their cage with a congener, autotomia never occurred.
Although rats lose weight for the first week after surgery, as a
consequence of hindlimb muscles atrophy, they subsequently
gained weight at the same rate as sham-operated rats, as expected
from animals in good health [44].
Effects of Spinal Cord Transection on Hindlimb Sensitivity
Just after the lesion, hindlimbs no longer responded by a reflex
motor reaction to cutaneous mechanical stimulation at high
intensity (with the 100 g von Frey filament). Motor reaction then
reappeared progressively up to a level corresponding to that found
in control (unoperated) animals around the second week post-
surgery. A marked hyper-reflexivity subsequently developed, along
with spasticity, which reached their maximum approximately 7
weeks post-surgery and were still fully present on the last day (60)
of our study. Marked alterations of motor reflexes also occur in
humans with complete spinal cord transection, as evidenced by the
exacerbated response in the H reflex of hindlimb muscles [45,46].
Such facilitated reflex responses may be due to a-motoneurons
hyperexcitability [47]. Indeed, spinal cord transection causes an
up-regulation of constitutively active 5-HT2C receptors expressed
by motoneurons, and the reinforcement of their membrane
depolarizing influence has been demonstrated to contribute to
motoneuron hyperexcitability in lesioned rats [48]. On the other
hand, spasticity could also be accounted for by a down regulation
of the potassium-chloride cotransporter KCC2 within the lumbar
spinal cord below transection [12]. Although spasticity can be
painful in humans, and below-level pain exists in patients with
extensive spinal cord injury [2,49], hyper-reflexivity and spasticity
at hindlimb level could not be related to pain behavior in SCT rats
because completeness of the lesion prevented the nociceptive
messages to reach the sensory cortex where they can generate pain
sensation.
Along with mechanical hypersensitivity, SCT rats also devel-
oped heat and cold hypersensitivity as shown by the reduced
latency of hindpaw withdrawal after immersion in water at 46uC
or 10uC (Fig.4). Heat hypersensitivity has already been described
in mice after spinal cord contusion and transection [50], and cold
hypersensitivity at hindpaw level has been well documented in rats
with contused spinal cord [51]. Whether or not similar
neuroplasticity mechanisms underlay thermal and mechanical
hypersensitivity at hindpaw level in SCT rats is a pending question
to be addressed in future studies. In particular, because thermal
hypersensitivity was evidenced from a motor response (hindpaw
Figure 7. Time-course changes in tissue levels of transcripts encoding ATF3 (A), OX-42 (B) or GFAP (C) in dorsal root ganglia and
spinal cord at various times after spinal cord transection. Real-time RT-qPCR determinations were made in T6–T8 and T9–T11 dorsal root
ganglia, T6–T8 and T9–T11 spinal cord segments and the cervical and lumbar enlargements at various times (in days, D, abscissa) after spinal cord
transection at T8–T9 level. Data are expressed as the ratio of specific mRNA over GaPDH mRNA [R.Q.(A.U.)]. Each bar is the mean + S.E.M. of n
independent determinations (D2, D4, D9, D15, D21: n = 6; D60: n = 12). Sham values at every postoperative time are pooled under ‘‘C’’ (control) on
abscissa. * P,0.05, * P,0.01, *** P,0.001 compared to respective values in sham-operated rats (C).Two-way ANOVA followed by Bonferroni test.
doi:10.1371/journal.pone.0102027.g007
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Figure 9. Short- and long-term changes in levels of transcripts encoding P264 (A), P267 (B) and TLR4 (C) in dorsal root ganglia and
spinal tissues in spinal cord-transected rats. Real-time RT-qPCR determinations were made in T6–T8 and T9–T11 dorsal root ganglia and T6–T8
and T9–T11 spinal segments at day 2 or 60 (abscissa) after spinal cord transection at T8–T9 level. Data are expressed as the ratio of specific mRNA
over GaPDH mRNA [R.Q.(A.U.)]. Each bar is the mean + S.E.M. of n independent determinations (D2: n = 6; D60: n = 12). Sham values at every
postoperative time are pooled under ‘‘C’’ (control) on abscissa. ** P,0.01, *** P,0.001 compared to respective levels in sham-operated rats (C). Two-
way ANOVA followed by Bonferroni test.
doi:10.1371/journal.pone.0102027.g009
Figure 8. Short- and long-term changes in levels of transcripts encoding IL-6 (A), IL-1b (B), TNF-a (C) and IL-10 in dorsal root ganglia
and spinal tissues in spinal cord-transected rats. Real-time RT-qPCR determinations were made in T6–T8 and T9–T11 dorsal root ganglia and
T6–T8 and T9–T11 spinal segments at day (D) 2, 15 or 60 (abscissa) after spinal cord transection at T8–T9 level. Data are expressed as the ratio of
specific mRNA over GaPDH mRNA [R.Q.(A.U.)]. Each bar is the mean + S.E.M. of n independent determinations (D2, D15: n = 6; D60: n = 12). Sham
values at every postoperative time are pooled under ‘‘C’’ (control) on abscissa. * P,0.05, * P,0.01, *** P,0.001 compared to respective values in
sham-operated rats (C). Two-way ANOVA followed by Bonferroni test.
doi:10.1371/journal.pone.0102027.g008
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withdrawal), it might have also involved – at least in part - some a-
motoneuron hyperexcitability as discussed above about SCT-
induced mechanical hypersensitivity.
At-Level Allodynia
Whereas no behavioral reaction to the application of von Frey
filaments within the trunk caudal to the lesion could be elicited in
SCT rats, at-level allodynia-like reactions appeared relatively
rapidly and reached a maximum 2–3 weeks after surgery. In
particular, biting, which is considered as a brainstem response, and
escape as a cortical response, were very probably associated with
pain in SCT rats [5]. Since sham-operated rats did not develop
such behaviors, we can exclude that they might have corresponded
to musculoskeletal pain. Instead, at-level mechanical allodynia
pain was very probably caused by spinal cord injury itself, as
expected of neuropathic pain of central (spinal) origin [2].
Interestingly, 100% of SCT rats developed at-level allodynia,
contrary to humans with spinal cord lesion and rats with spinal
cord contusion as only a fraction of lesioned subjects suffer from
such pain symptoms. Indeed, the prevalence for the rat/human to
develop at-level pain depends on the extent of the lesion [52].
Such homogeneous data in SCT rats support the idea that the
SCT model might be especially useful to assess the potential effects
of drugs aimed at reducing centrally-evoked neuropathic pain and
to investigate underlying physiopathological mechanisms.
Even though at-level cold allodynia is frequently seen in SCI
patients [53], only few studies have reported this symptom in
spinal cord lesioned rodents [5,54]. Indeed, according to Baastrup
et al. [5], only 3% of the rats with contusion of the spinal cord
exhibit clear-cut cold allodynia. In contrast, in our study, 100% of
SCT rats presented at-level cold allodynia further emphasizing the
usefulness of this model for improving experimental group
homogeneity. A potential at-level heat allodynia could not be
assessed in our studies because of the unavailability of appropriate
equipment. Nevertheless, it can be recalled that using a Peltier
device, Gao et al. [54] were unable to detect any heat allodynia in
spinal cord contused rats.
Pharmacological Sensitivity of At-Level Mechanical
Allodynia in SCT Rats
Only a few drugs among those tested were found to efficiently
reduce at-level allodynia when injected acutely in SCT rats. The
efficacy of morphine and tapentadol was probably underlain by
the capacity of mu opioid receptor activation to inhibit the activity
of wide dynamic range neurons in the dorsal horn of the spinal
cord [55]. Interestingly, tapentadol had a somewhat more
prolonged effect than morphine, may be because of its additional
capacity to inhibit noradrenaline reuptake as this monoamine has
been shown to be implicated in descending inhibitory control of
neuropathic pain [56].
Ketamine also reversed at-level allodynia in SCT rats, in
consistence with human data that demonstrated that this NMDA
receptor antagonist is especially efficient to reduce allodynia in
SCI patients [57]. This marked effect of ketamine, that may be
sustained by a temporary inhibition of astrocyte activation, further
supports the key role played by glutamate receptors, particularly
NMDA receptors, in physiopathological mechanisms underlying
neuropathic pain [58].
Finally, the last drug of the series tested which was found to
exert some (but modest) anti-allodynic effects in SCT rats was the
GABA B receptor agonist, baclofen, commonly used to suppress
spasticity in spinal cord injured patients [59]. Spinal cord injury is
known to be associated with a decreased tone of inhibitory
GABAergic neurotransmission [7], and it can be proposed that
baclofen transiently compensated for this deficit, thereby reducing
allodynia in SCT rats. In contrast, clonazepam, which is used to
alleviate SCI patients from neuropathic pain [27], was inefficient
suggesting that GABA A receptor activation was ineffective to
inhibit at-level allodynia in SCT rats.
Serotonin is known to play a major role in pain control via the
activation of several receptor types [36]. Thus, F13640, a potent
and selective 5-HT1A receptor agonist, appeared to be especially
effective to suppress allodynia in spinal cord lesioned rats [60]. In
our hands, the prototypical 5-HT1A receptor agonist, 8-OH-
DPAT, did not reduce allodynia in SCT rats. Yet, this molecule is
also an agonist at 5-HT7 receptors, whose activation can result in
effects opposite to that expected from 5-HT1A receptor activation
[61]. Further studies with selective 5-HT1A and 5-HT7 receptor
ligands have therefore to be performed in order to reach a clear-
cut conclusion regarding the potential modulations of at-level
allodynia by serotonin acting at these receptors.
Because allodynia-like sensory dysfunctions are associated with
migraine [62], we also investigated whether the anti-migraine
drug, naratriptan, with potent 5-HT1B/1D receptor agonist
properties [36], could alleviate at-level allodynia in SCT rats.
Indeed, no effect was observed, possibly because triptans were
found to selectively reduce neuropathic pain at cephalic level but
not in extra-cephalic territories [35]. Finally, the last 5-HT
receptor that we selected for our pharmacological investigations
was the 5-HT3 type whose implication in modulatory controls of
neuropathic pain has been firmly established [63]. In contrast to
the capacity of i.t. injection of ondansetron to attenuate
neuropathic pain caused by spinal cord compression [64], this
treatment was inactive in SCT rats, probably because complete
transection of the spinal cord had suppressed the bulbo-spinal
connections involved in 5-HT3 receptor-mediated effects [38].
Under our acute treatment conditions, neither the antidepres-
sant amitriptyline nor the anticonvulsants gabapentin and
pregabalin, which are commonly used to reduce neuropathic pain
in SCI patients [3], exerted any significant anti-allodynic effect in
SCT rats (Table 1). Indeed, numerous studies showed that these
drugs are effective only under chronic treatment conditions
[39,65], and further experiments consisting of repeated adminis-
trations of antidepressants and anticonvulsants have to be
performed before concluding about their effectiveness or ineffec-
tiveness in the SCT rat model.
Finally, because BDNF and its receptor TrkB play key roles in
physiopathological mechanisms underlying neuropathic pain
[66,67], we investigated whether acute TrkB blockade by
cyclotraxin B could affect allodynia in SCT rats. Indeed,
Constandil et al. [34] reported that this drug can prevent and
reverse neuropathic pain caused by peripheral nerve ligation in
rats. In contrast, we found that cyclotraxin B was unable to reduce
allodynia in SCT rats (Table 1), in line with RT-qPCR
determinations which suggested that spinal BDNF expression
would not be upregulated (in contrast to that observed in
peripheral neuropathic pain models [66,67]) but rather downreg-
ulated after thoracic cord transection, as previously reported after
other types of SCI in rats [68,69].
Neuroinflammation and Glial Activation in SCT Rats
The transcription factor ATF3 is induced when neurons are
injured, and implicated in regeneration and plasticity [21]. Its role
in the maintenance of central neuropathic pain is the matter of
controversy, as it is no longer expressed when pain is still present
after spinal cord injury [70]. However, ATF3 implication in the
induction of central neuropathic pain is supported by data showing
that it promotes the expression of the microglial/macrophage
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marker OX-42 and the astrocyte/satellite glial cell marker GFAP
[71,72], two factors closely associated with neural lesion-evoked
neuropathic pain [21,70,73–75]. Because ATF3 activation is
triggered by cellular damages, and this transcription factor is able
to repress its own promoter [71], the long lasting up-regulation of
ATF3 transcript that occurred after SCT might reflect an ongoing
neuronal damage associated with microglia activation. Convergent
data in the literature showed that microglia activation is mediated,
among others, by purinergic receptors [76] and Toll-Like
Receptors [77]. Consistently, we observed, in thoracic cord
segments just caudal (T9–T11) and rostral (T6–T8) to the
transection, a long lasting (up to 60 days post-surgery) increase
in the expression of mRNAs encoding P2XA, P267 and TLR4
receptors.
Numerous reports in the literature ascribe to activated microglia
an important role in neuropathic pain consecutive to spinal cord
injury [70,73,78], and the marked induction of OX42 mRNA in
SCT rats is congruent with these data. In fact, IL-6, IL-1b, and
TNF-a cytokines released from activated microglia can induce, by
themselves, central (spinal) sensitization, thus maintaining neuro-
pathic pain [79,80]. The huge induction of IL-6 and IL-1b that
occurred on day 2 post-surgery suggests that these cytokines were
involved more in the induction than in the maintenance of SCT-
evoked neuropathic pain. In contrast, TNF-a would be more
concerned by pain maintenance as SCT-induced up-regulation of its
transcript in spinal T6–T8 segments was as pronounced at day 60
as at day 2 post-surgery. The strong increase in IL-10 mRNA that
occurred shortly after the lesion might be linked to some inhibitory
control of neuropathic pain for the first days after SCT, through
the anti-inflammatory potency of this cytokine [81] and/or its
neuroprotective effects in spinal cord injured models [82]. Overall,
in contrast to that found in spinal tissues, none of the 11 genes
studied were up-regulated beyond two weeks post-surgery in DRG
above the lesion, supporting the idea that SCT-induced long
lasting at-level allodynia did not involve some peripheral
hypersensitivity but corresponded mainly, if not exclusively, to
central neuropathic pain. Indeed, the short lasting induction of
ATF3, OX-42, GFAP and cytokines encoding genes in DRG
might have reflected some limited lesion of T8–T9 dorsal roots
possibly occurring during surgery for thoracic cord transection. As
a matter of fact, it has to be emphasized that our RT-qPCR
determinations of time-course changes in mRNA levels will have
to be completed by measurements of corresponding proteins in
order to validate the inferences made above about the respective
implications of pro-inflammatory cytokines and other neuroin-
flammatory markers in neuropathic pain-inducing mechanisms in
SCT rats.
Within the spinal cord, GFAP mRNA up-regulation after SCT
was delayed compared to that of transcripts encoding the pro-
inflammatory cytokines IL-1b, IL-6 and TNF-a, in line with the
idea that early production and release of these cytokines from
microglial activation [83] leads to secondary induction of
astrogliosis after injury [84]. That astrogliosis with an up-
regulation of GFAP [74] - like that found in SCT rats - contributes
to neuropathic pain after spinal cord injury is supported by the fact
that pharmacological blockade of astroglia activation reduced pain
in spinal cord-lesioned rats [73,85].
Conclusion
Spinal cord transection at thoracic level in rats appeared to
generate a highly reproducible model of at-level neuropathic pain,
mainly of central origin, suitable for pharmacological studies
aimed at testing innovative treatments targeted specifically on
spinal lesion-evoked neuropathic pain. Time course changes in
mRNA levels of neuroinflammatory markers induced by the lesion
supported the idea that both activated microglia and activated
astroglia contributed to neuropathic pain in spinally transected
rats. However, further investigations of these markers have to be
made at protein level in order to determine more precisely the
respective roles of both cell types in mechanisms underlying
central allodynia in SCT rats.
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